|
IM-MV 18-005_006
|
Universitair Medisch Centrum Utrecht
|
Clinical development program for a gene replacement therapy for patients with Spinal Muscular Atrophy utilizing AVXS-101, an adeno-associated viral vector serotype 2/9 containing the human SMN gene.
|
31-05-2022
|
Vergunning verleend
|
|
IM-MV 18-010_006
|
Prinses Máxima Centrum
|
Testing the safety and efficacy of JCAR017 in patients with aggressive B cell malignancies
|
15-06-2022
|
Vergunning verleend
|
|
IM-MV 20-010_003
|
Erasmus MC
|
MVA-MERS-S_DF1: An MVA-vectored vaccine candidate against MERS coronavirus, encoding the MERS spike protein
|
19-07-2022
|
Vergunning verleend
|
|
IM-MV 21-011_000
|
AMC
|
AAV clinical vectors with a target nuclease as insert, used in vivo, to treat and/or prevent disease
|
|
Ontwerpbesluit genomen
|
